Session » Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases

Date: Tuesday, November 12, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2069

Alcohol Consumption Is Not an Independent Predictor of Fatigue Severity over Time

9:00AM-11:00AM: Abstract Number: 2062

Arthritis, Physical Function, and Disability Among Older Mexican Americans over 20-Years of Follow-up

9:00AM-11:00AM: Abstract Number: 2063

Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)

9:00AM-11:00AM: Abstract Number: 2065

Association Between Anemia and Hyperuricemia: Korean National Health and Nutrition Survey 2016-2017

9:00AM-11:00AM: Abstract Number: 2050

Association of Gout with Vitamin D: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 2061

Association of Periodontitis with Rheumatological Disorders: NHANES III Analysis

9:00AM-11:00AM: Abstract Number: 2052

Association of Traumatic Knee Injury with Knee Function, Symptoms, and Radiographic Osteoarthritis in Military Officers

9:00AM-11:00AM: Abstract Number: 2074

Automated Diagnosis Extraction from Electronic Medical Records with Machine Learning Classifiers

9:00AM-11:00AM: Abstract Number: 2068

Body Mass Index and Systemic Corticosteroid Use as Indicators of Disease Burden and Their Influence on the Safety Profile of Certolizumab Pegol Across Indications

9:00AM-11:00AM: Abstract Number: 2066

Clinical, Serologic and Morphologic Features of Interstitial Pneumonia with Autoimmune Features (IPAF): A Single Center Experience

9:00AM-11:00AM: Abstract Number: 2070

Co-morbidities in Patients with OA and RA: Results from a Large US Rheumatic Disease Registry

9:00AM-11:00AM: Abstract Number: 2067

Comparison of Medication New User Definitions in Multi-Specialty EMR Data

9:00AM-11:00AM: Abstract Number: 2057

Cross-sectional Associations of Multiple Joint Osteoarthritis in the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2075

Cross-sectional Study and Mendelian Randomization Analysis of Diet in Six Prevalent Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 2054

Epidemiology of Gout in South Korea with the National Health Insurance Corporation Database

9:00AM-11:00AM: Abstract Number: 2064

Evaluation of Methods to Account for Differential Follow-up When Comparing Clinical Trial Data to Observational Data

9:00AM-11:00AM: Abstract Number: 2051

Factors in Achieving Serum Uric Acid Target and the Occurrence of Gouty Arthritis: A Cross-sectional Study Based on Japanese Health Insurance Claim Data

9:00AM-11:00AM: Abstract Number: 2055

High Dietary Sodium Intake May Be Associated with Symptomatic Knee Osteoarthritis in a Korean Population: Korean National Health and Nutrition Examination Survey, 2010-2011

9:00AM-11:00AM: Abstract Number: 2049

National Estimates of Pain Medication Use in Patients with Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2048

Opioid Prescription Use Among Patients with Rheumatic Disease: A Population Based Cohort Study

9:00AM-11:00AM: Abstract Number: 2056

Opioids Use Among Medicare Beneficiaries with Knee Osteoarthritis: Prevalence and Correlates of Chronic Use

9:00AM-11:00AM: Abstract Number: 2058

Pharmacoepidemiology of Gout Treatment in Office-based Outpatient Care from 2009- 2016

9:00AM-11:00AM: Abstract Number: 2077

Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia and the Fallacy of the Variance Explained

9:00AM-11:00AM: Abstract Number: 2072

Prevalence of Thyroid Dysfunction with Therapeutic Indication in Patients with Rheumatological Diseases

9:00AM-11:00AM: Abstract Number: 2053

Risk of Non-vertebral Fracture in Gout Compared to Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2073

The Association of Serum Uric Acid Levels and the Risk of Lower Urinary Tract Symptoms in Korean Healthy Adults

9:00AM-11:00AM: Abstract Number: 2060

The Current State of Big Data Use and Artificial Intelligence in RMDs: A Systematic Literature Review Informing EULAR Recommendations

9:00AM-11:00AM: Abstract Number: 2076

The Opioid Epidemic: The Rheumatology Response to Management of Chronic Pain

9:00AM-11:00AM: Abstract Number: 2071

The Prevalence of 78 Autoimmune Diseases in Catalonia (MASCAT-PADRIS Big Data Project)

9:00AM-11:00AM: Abstract Number: 2047

Time-trends in Opioid Use Hospitalizations in Common Musculoskeletal Conditions: Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain

9:00AM-11:00AM: Abstract Number: 2059

Usage of Predicting Out-of-Office Blood Pressure Calculator in Hispanic Patients with Rheumatic Diseases

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].